Book Your Appointment
Verified Patient Reviews of DCDC Diagnostic Center in Dubai
Verified reviews and real patient stories from Dubai Healthcare City
I'm very satisfied with this medical clinic. I had my first pregnancy screening here. It was affordable and very professional. The radiologist was welcoming, kind, and made the experience great.
Aizhan Tokmanbetova
Hurt my knee Friday night and got an MRI appointment Sunday evening (booked Sunday afternoon). Waited about 2 minutes and was done in just over 30 minutes. The team was amazing, friendly and efficient.
Kirsten Evans
Dr. Osama's team was gentle and amazing. After a bad experience elsewhere, my pelvic exam here was much more professional. Great report and very precise.
Mary
Shingrix Vaccine in Dubai: Shingles Prevention for Adults 50+ and Immunocompromised
The Gold Standard in Herpes Zoster Prevention with Over 90% Efficacy
Over 90% Effective
Proven protection lasting seven or more years
Two-Dose Schedule
Second dose at 2-6 months for full protection
Safe for Immunocompromised
Non-live vaccine suitable for high-risk adults
The Shingrix vaccine is the most effective protection available against shingles (herpes zoster) and its most debilitating complication, postherpetic neuralgia. At Doctors Clinic Diagnostic Center in Dubai Healthcare City, we administer the complete two-dose SHINGRIX series for adults aged 50 and over, as well as immunocompromised adults aged 19 and over who are at increased risk of shingles reactivation.
SHINGRIX is a recombinant, adjuvanted vaccine that provides over 90 percent protection against shingles in adults aged 50 and older — a level of efficacy that remains strong for at least seven years after vaccination. Unlike the older live-attenuated shingles vaccine (Zostavax), SHINGRIX is not a live vaccine, making it safe for immunocompromised individuals including those undergoing chemotherapy, taking immunosuppressive medications, or living with HIV. The two-dose schedule, with the second dose given two to six months after the first, is essential for achieving full protection.
Shingles occurs when the varicella-zoster virus, which remains dormant in nerve cells after a childhood chickenpox infection, reactivates later in life. The risk of shingles increases significantly after age 50 as natural immunity wanes, and approximately one in three people who have had chickenpox will develop shingles during their lifetime. The hallmark symptom is a painful, blistering rash that typically appears in a band or strip on one side of the body, often accompanied by burning, tingling, and intense nerve pain that can persist for months or even years after the rash heals — a condition known as postherpetic neuralgia.
Our physicians provide personalized consultation before vaccination, reviewing your medical history, current medications, immune status, and any previous shingles episodes. Even patients who have previously had shingles should receive SHINGRIX, as the virus can reactivate more than once. We schedule both doses appropriately and provide aftercare guidance to manage the common mild side effects, which include injection site soreness, fatigue, and muscle aches lasting two to three days.
The decision to vaccinate against shingles at age 50 or older is one of the highest-value preventive health choices an adult can make. Postherpetic neuralgia, which affects up to 30 percent of unvaccinated shingles patients over age 60, causes chronic burning or stabbing pain that can last months to years and is often resistant to standard pain medications. SHINGRIX reduces the risk of shingles by over 90 percent and the risk of postherpetic neuralgia by over 89 percent, offering substantial protection against both the acute illness and its most feared long-term consequence.
Over 90% Effective
Proven protection lasting seven or more years
Two-Dose Schedule
Second dose at 2-6 months for full protection
Safe for Immunocompromised
Non-live vaccine suitable for high-risk adults
Shingrix Vaccine in Dubai: Shingles Prevention for Adults 50+ and Immunocompromised
The Gold Standard in Herpes Zoster Prevention with Over 90% Efficacy
The Shingrix vaccine is the most effective protection available against shingles (herpes zoster) and its most debilitating complication, postherpetic neuralgia. At Doctors Clinic Diagnostic Center in Dubai Healthcare City, we administer the complete two-dose SHINGRIX series for adults aged 50 and over, as well as immunocompromised adults aged 19 and over who are at increased risk of shingles reactivation.
SHINGRIX is a recombinant, adjuvanted vaccine that provides over 90 percent protection against shingles in adults aged 50 and older — a level of efficacy that remains strong for at least seven years after vaccination. Unlike the older live-attenuated shingles vaccine (Zostavax), SHINGRIX is not a live vaccine, making it safe for immunocompromised individuals including those undergoing chemotherapy, taking immunosuppressive medications, or living with HIV. The two-dose schedule, with the second dose given two to six months after the first, is essential for achieving full protection.
Shingles occurs when the varicella-zoster virus, which remains dormant in nerve cells after a childhood chickenpox infection, reactivates later in life. The risk of shingles increases significantly after age 50 as natural immunity wanes, and approximately one in three people who have had chickenpox will develop shingles during their lifetime. The hallmark symptom is a painful, blistering rash that typically appears in a band or strip on one side of the body, often accompanied by burning, tingling, and intense nerve pain that can persist for months or even years after the rash heals — a condition known as postherpetic neuralgia.
Our physicians provide personalized consultation before vaccination, reviewing your medical history, current medications, immune status, and any previous shingles episodes. Even patients who have previously had shingles should receive SHINGRIX, as the virus can reactivate more than once. We schedule both doses appropriately and provide aftercare guidance to manage the common mild side effects, which include injection site soreness, fatigue, and muscle aches lasting two to three days.
The decision to vaccinate against shingles at age 50 or older is one of the highest-value preventive health choices an adult can make. Postherpetic neuralgia, which affects up to 30 percent of unvaccinated shingles patients over age 60, causes chronic burning or stabbing pain that can last months to years and is often resistant to standard pain medications. SHINGRIX reduces the risk of shingles by over 90 percent and the risk of postherpetic neuralgia by over 89 percent, offering substantial protection against both the acute illness and its most feared long-term consequence.
Explore Our Services
Comprehensive shingles vaccine (shingrix) services at DCDC Dubai Healthcare City.
All services performed by DHA-licensed specialists
Who Should Get the Shingrix Vaccine?
The Shingrix vaccine is recommended for specific adult populations based on age, immune status, and shingles history. Our physician will confirm your eligibility during a pre-vaccination consultation.
All adults aged 50 and over, regardless of whether they recall having chickenpox
Adults aged 50 and over who have previously had shingles, as reactivation can occur again
Immunocompromised adults aged 19 and over, including those on chemotherapy or biologics
Adults living with HIV, regardless of CD4 count, from age 19 onward
Patients who previously received the older Zostavax vaccine and need updated protection
Adults taking long-term immunosuppressive medications such as corticosteroids or methotrexate
Why Choose DCDC for the Shingrix Vaccine in Dubai?
MOHAP-licensed clinic in Dubai Healthcare City offering the SHINGRIX two-dose series with cold-chain certified storage, personalized consultation, and convenient scheduling.
MOHAP Licensed Clinic
Licensed DHCC facility (MOHAP license NIMY7VY5-240925) with certified cold-chain vaccine storage meeting international standards.
Over 90% Efficacy
SHINGRIX delivers over 90 percent protection against shingles, sustained for seven or more years.
All Eligible Adults
Administered to adults 50+ and immunocompromised adults 19+ including chemotherapy and HIV patients.
Flexible Scheduling
Both doses scheduled at your convenience with the second dose two to six months after the first.
Personalized Consultation
Physician reviews your history, medications, and immune status before recommending vaccination.
Prime DHCC Location
Building 64, Block A, DCDC — easily accessible from Bur Dubai and nearby areas.
Your Comfortable Visit
A simple, step-by-step Shingles scan process designed for comfort, speed, and accuracy.
Shingrix Vaccine Fees in Dubai
Shingles pricing in Dubai varies by service type and insurance coverage for various service types.
- Pricing varies by scan type and whether contrast is required
- Insurance coverage accepted with referral and verification
- Transparent self-pay rates available with instant quote on request
Insurance verification in minutes • No hidden fees • Fast response on WhatsApp
Patient Guide
What to Expect at Your Shingrix Vaccination Visit
Our physician-led approach ensures safe administration, proper scheduling of both doses, and clear aftercare guidance.
Insurance & Location
Insurance Partners
- •20+ insurance providers in Dubai including Daman, AXA, ADNIC, and others
- •Pre-authorization support and direct billing (where applicable)
- •Coverage verification before your appointment at our Dubai Healthcare City clinic
- •Transparent pricing with no hidden fees for shingles vaccine (shingrix) services
Visit Us in Dubai Healthcare City
Doctors Clinic Diagnostic Center
Building 64, Block A, Al Razi Medical Complex, Dubai Healthcare City, Dubai, UAE
Near Oud Metha Road · Easy access from Bur Dubai, Downtown Dubai, Business Bay · Free dedicated parking available
Working Hours
Mon-Thu, Sat: 8AM - 10:30PM | Sun: 8:30AM - 10:30PM | Fri: 9AM - 10PM
How Insurance Works at DCDC
Check Coverage
Verify your plan covers Shingles Vaccine (SHINGRIX)
Get a Referral
Some insurers require a GP referral — we can guide you
Pre-Authorization
We handle pre-auth directly with your insurer
Direct Billing
No upfront payment — we bill your insurer directly
Co-Pay Only
You only pay any applicable co-pay at the clinic
Check Coverage
Verify your plan covers Shingles Vaccine (SHINGRIX)
Get a Referral
Some insurers require a GP referral — we can guide you
Pre-Authorization
We handle pre-auth directly with your insurer
Direct Billing
No upfront payment — we bill your insurer directly
Co-Pay Only
You only pay any applicable co-pay at the clinic
Patient Guide
Understanding Shingles: Why the Shingrix Vaccine Is Essential for Adults 50+
Shingles, medically known as herpes zoster, is caused by the reactivation of the varicella-zoster virus (VZV) — the same virus that causes chickenpox in childhood. After a person recovers from chickenpox, the virus does not leave the body; instead, it becomes dormant in nerve cells near the spinal cord and brain, where it can remain inactive for decades. As natural immunity declines with age, stress, illness, or immunosuppressive treatment, the virus can reactivate and travel along nerve fibers to the skin, causing the characteristic painful, blistering rash of shingles. According to the Centers for Disease Control and Prevention, approximately one in three people who have had chickenpox will develop shingles during their lifetime.
The risk of shingles increases dramatically after age 50, with the highest incidence occurring in adults over 70. The acute phase of shingles typically lasts two to four weeks and is characterized by a burning, tingling sensation followed by a painful rash of fluid-filled blisters, usually appearing in a band or strip on one side of the torso, although it can also affect the face, eyes, and ears. When shingles affects the ophthalmic branch of the trigeminal nerve (herpes zoster ophthalmicus), it can cause serious eye complications including corneal scarring and vision loss if not treated promptly. The pain of shingles is often described as one of the most intense pain experiences in medicine.
Postherpetic neuralgia (PHN) is the most common and feared complication of shingles, occurring when the virus damages nerve fibers during reactivation. PHN causes chronic burning, stabbing, or throbbing pain in the area where the shingles rash occurred, persisting for months or even years after the rash has healed. The risk of PHN increases sharply with age: it affects approximately 10 to 13 percent of shingles patients over age 50, rising to 30 percent or more in those over age 60. PHN pain is often resistant to standard analgesics and can significantly impact quality of life, causing sleep disturbance, depression, weight loss, and functional disability. The SHINGRIX vaccine reduces the risk of PHN by over 89 percent.
The development of SHINGRIX represented a major advancement in shingles prevention. Approved by the US FDA in 2017 and subsequently adopted worldwide, SHINGRIX is a recombinant vaccine containing glycoprotein E — a protein found on the surface of the varicella-zoster virus that is essential for viral replication and cell-to-cell spread. The vaccine also contains a novel adjuvant system (AS01B) that dramatically enhances the immune response, producing both strong antibody levels and robust cellular immunity. In landmark clinical trials involving over 38,000 adults, SHINGRIX demonstrated 97.2 percent efficacy in adults aged 50 to 69 and 91.3 percent efficacy in adults aged 70 and over — efficacy levels that remained above 85 percent for at least seven years of follow-up. This represents a transformative improvement over the older Zostavax vaccine, which had only 51 percent efficacy that declined significantly within several years. For adults seeking a shingles vaccine Dubai or a herpes zoster vaccine with proven long-term protection, SHINGRIX is the clear choice.
Conditions Prevented by the Shingrix Vaccine
Shingles (Herpes Zoster)
Painful reactivation of dormant varicella-zoster virus causing a blistering rash along nerve pathways, typically on one side of the body, lasting two to four weeks with intense burning and tingling pain. The herpes zoster vaccine SHINGRIX prevents this reactivation with over 90 percent efficacy.
Postherpetic Neuralgia
Chronic nerve pain persisting for months or years after shingles rash heals, caused by virus-induced nerve fiber damage. Affects up to 30 percent of unvaccinated patients over age 60 and is often resistant to standard pain medications.
Herpes Zoster Ophthalmicus
Shingles affecting the ophthalmic branch of the trigeminal nerve, causing eye pain, corneal inflammation, and potential vision loss if not treated promptly. Accounts for 10 to 20 percent of all shingles cases.
Zoster-Associated Neurological Complications
Rare but serious complications including stroke from virus-induced inflammation of cerebral blood vessels (VZV vasculopathy), facial paralysis (Ramsay Hunt syndrome), and meningoencephalitis.
Disseminated Herpes Zoster
Widespread shingles affecting multiple dermatomes and potentially internal organs, occurring primarily in immunocompromised patients and carrying significant morbidity and mortality risk.
Related Services
Explore other diagnostic and consultation services available at our Dubai Healthcare City clinic.
Frequently Asked Questions
Common questions about Shingles Vaccine (SHINGRIX) in Dubai.
The Shingrix vaccine is a recombinant, adjuvanted vaccine that stimulates your immune system to recognize and fight the varicella-zoster virus, which causes shingles. Unlike older live-attenuated vaccines, SHINGRIX contains a non-living piece of the virus (glycoprotein E) combined with an adjuvant that enhances the immune response. This design produces strong, long-lasting immunity with over 90 percent efficacy against shingles and postherpetic neuralgia, maintained for at least seven years. The two-dose schedule is essential for achieving full protection.
As the most effective shingles vaccine Dubai clinics offer, SHINGRIX is recommended for all adults aged 50 and over, regardless of whether they recall having chickenpox, as over 99 percent of adults born before 1980 carry the dormant varicella-zoster virus. It is also recommended for immunocompromised adults aged 19 and over, including those on chemotherapy, biologics, long-term corticosteroids, or anti-rejection medications after organ transplant. Even if you have previously had shingles or received the older Zostavax vaccine, you should still receive the two-dose SHINGRIX series for updated, stronger protection.
SHINGRIX is administered as an intramuscular injection in the deltoid muscle of the upper arm. The complete series requires two doses. The second dose should be given two to six months after the first dose. If the second dose is delayed beyond six months, you do not need to restart the series — simply receive the second dose as soon as possible. Both doses are necessary for full protection; a single dose provides only partial immunity.
SHINGRIX commonly causes injection site soreness, redness, and swelling, as well as systemic reactions including fatigue, muscle aches, headache, shivering, and mild fever. These side effects typically begin within 24 hours and resolve within two to three days. They tend to be more pronounced than typical vaccine reactions because SHINGRIX contains a potent adjuvant designed to stimulate a strong immune response. The side effects are generally well-tolerated and are not a reason to skip the second dose. Over-the-counter paracetamol or ibuprofen can help manage discomfort.
Yes, receiving the Shingrix vaccine after a previous shingles episode is strongly recommended. The varicella-zoster virus can reactivate more than once, and a prior episode does not provide reliable long-term protection against future reactivation. We recommend waiting until the acute shingles rash has fully resolved before receiving the first SHINGRIX dose. The two-dose series will then provide over 90 percent protection against future shingles episodes and postherpetic neuralgia.
Yes, SHINGRIX is a non-live recombinant vaccine, making it safe for immunocompromised individuals — a key advantage over the older live-attenuated Zostavax vaccine, which was contraindicated in this population. SHINGRIX is specifically recommended for adults aged 19 and over who are immunocompromised due to disease or treatment, including HIV infection, chemotherapy, organ transplant immunosuppression, and autoimmune conditions treated with biologics or long-term corticosteroids. Clinical trials in immunocompromised populations demonstrated strong efficacy and acceptable safety profiles.
If you miss the recommended two-to-six-month window for the second dose, you do not need to restart the series. Receive the second dose as soon as possible to complete your protection. However, you will not have full protection until the second dose has been administered and your immune system has responded, which takes approximately two to four weeks after the second injection. We recommend scheduling the second dose appointment at the time of your first dose to help ensure timely completion.
Yes, preventing postherpetic neuralgia is one of the most important benefits of the Shingrix vaccine. Clinical trials demonstrated over 89 percent efficacy in preventing postherpetic neuralgia in adults aged 50 and over. Postherpetic neuralgia occurs when shingles damages nerve fibers, causing chronic burning or stabbing pain that persists for months or years after the rash heals. It affects up to 30 percent of unvaccinated shingles patients over age 60 and is often resistant to standard pain medications. By preventing shingles itself, SHINGRIX dramatically reduces the risk of this debilitating chronic pain condition.
Medical Review & Oversight
All services are provided under the supervision of licensed medical professionals in our MOHAP-accredited facility.